Skip to main content
Top

Supportive Care in Cancer

Issue 6/1997

Content (15 Articles)

EDITORIAL

How safe are opioids in palliative care?

C. Mazzocato, F. Stiefel

SPECIAL ARTICLE

Quality of life and supportive care

Alan Coates

REVIEW ARTICLE

Organizational barriers in opioid use

Kathy Redmond

REVIEW ARTICLE

Pseudo-opioid-resistant pain

G. C. M. Evers

SHORT COMMUNICATION

Hypersensitivity reactions to parenteral lipid solutions

B. Weidmann, Christiane Lepique, Andrea Heider, Albert Schmitz, Norbert Niederle

SHORT COMMUNICATION

Palliative treatment at home for patients with haematological disorders

D. Stockelberg, Pirkko Lehtola, Inger Norén

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine